Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002198
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients
Sponsor:
Glaxo Wellcome
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Study to Investigate Whether There is a Pharmacokinetic Interaction Between 1592U89 and Ethanol Following Their Co-Administration to HIV-Infected Subjects
Status:
COMPLETED
Status Verified Date:
1997-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to see how the body processes 1592U89 and ethanol pure grain alcohol when they are given together
Detailed Description:
Patients are randomized to one of the following three regimens
Regimen 1 1592U89 alone Regimen 2 pure grain alcohol diluted in orange juice Regimen 3 1592U89 plus pure grain alcohol diluted in orange juice Treatment is administered weekly for 3 weeks
Regimen 1 1592U89 alone Regimen 2 pure grain alcohol diluted in orange juice Regimen 3 1592U89 plus pure grain alcohol diluted in orange juice Treatment is administered weekly for 3 weeks
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CNAA 1010 | None | None | None |